272 related articles for article (PubMed ID: 25724088)
21. Esophageal stenting and radiotherapy: a multimodal approach for the palliation of symptomatic malignant dysphagia.
Rueth NM; Shaw D; D'Cunha J; Cho C; Maddaus MA; Andrade RS
Ann Surg Oncol; 2012 Dec; 19(13):4223-8. PubMed ID: 22752374
[TBL] [Abstract][Full Text] [Related]
22. Acceptable results after self-expanding metallic stent treatment for dysphagia in non-resectable oesophageal cancer.
Bjerring OS; Pless T; Fristrup C; Mortensen MB
Dan Med J; 2012 Jun; 59(6):A4459. PubMed ID: 22677249
[TBL] [Abstract][Full Text] [Related]
23. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study.
Siddiqui AA; Glynn C; Loren D; Kowalski T
Dis Esophagus; 2009; 22(3):216-22. PubMed ID: 19207544
[TBL] [Abstract][Full Text] [Related]
24. Role of photodynamic therapy in the palliation of obstructing esophageal cancer.
Yoon HY; Cheon YK; Choi HJ; Shim CS
Korean J Intern Med; 2012 Sep; 27(3):278-84. PubMed ID: 23019392
[TBL] [Abstract][Full Text] [Related]
25. Esophageal stent placement without fluoroscopy.
White RE; Mungatana C; Topazian M
Gastrointest Endosc; 2001 Mar; 53(3):348-51. PubMed ID: 11231400
[TBL] [Abstract][Full Text] [Related]
26. Fully covered removable nitinol self-expandable metal stents (SEMS) in malignant strictures of the esophagus: a multicenter analysis.
Talreja JP; Eloubeidi MA; Sauer BG; Al-Awabdy BS; Lopes T; Kahaleh M; Shami VM
Surg Endosc; 2012 Jun; 26(6):1664-9. PubMed ID: 22179474
[TBL] [Abstract][Full Text] [Related]
27. Polytetrafluoroethylene-covered retrievable expandable nitinol stents for malignant esophageal obstructions: factors influencing the outcome of 270 patients.
Park JH; Song HY; Kim JH; Jung HY; Kim JH; Kim SB; Lee H
AJR Am J Roentgenol; 2012 Dec; 199(6):1380-6. PubMed ID: 23169734
[TBL] [Abstract][Full Text] [Related]
28. Gastric ulceration following oesophageal stent migration complicating surgical management of oesophageal cancer.
Markar SR; Ross A; Low DE
Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):320-2. PubMed ID: 22593562
[TBL] [Abstract][Full Text] [Related]
29. A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety.
Brown RE; Abbas AE; Ellis S; Williams S; Scoggins CR; McMasters KM; Martin RC
J Am Coll Surg; 2011 Apr; 212(4):582-8; discussion 588-9. PubMed ID: 21463793
[TBL] [Abstract][Full Text] [Related]
30. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
[TBL] [Abstract][Full Text] [Related]
31. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
32. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma.
Homs MY; Steyerberg EW; Kuipers EJ; van der Gaast A; Haringsma J; van Blankenstein M; Siersema PD
Endoscopy; 2004 Oct; 36(10):880-6. PubMed ID: 15452784
[TBL] [Abstract][Full Text] [Related]
33. Migration of retrievable expandable metallic stents inserted for malignant esophageal strictures: incidence, management, and prognostic factors in 332 patients.
Park JH; Song HY; Shin JH; Cho YC; Kim JH; Kim SH; Park J
AJR Am J Roentgenol; 2015 May; 204(5):1109-14. PubMed ID: 25905949
[TBL] [Abstract][Full Text] [Related]
34. Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study.
Siddiqui AA; Loren D; Dudnick R; Kowalski T
Dig Dis Sci; 2007 Mar; 52(3):823-9. PubMed ID: 17253137
[TBL] [Abstract][Full Text] [Related]
35. Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy.
Langer FB; Schoppmann SF; Prager G; Tomaselli F; Pluschnig U; Hejna M; Schmid R; Zacherl J
Ann Surg Oncol; 2010 Feb; 17(2):470-5. PubMed ID: 19859771
[TBL] [Abstract][Full Text] [Related]
36. Self-expandable metallic stent placement for patients with inoperable esophageal carcinoma: investigation of the influence of prior radiotherapy and chemotherapy.
Iraha Y; Murayama S; Toita T; Utsunomiya T; Nagata O; Akamine T; Ogawa K; Adachi G; Tanigawa N
Radiat Med; 2006 May; 24(4):247-52. PubMed ID: 16958397
[TBL] [Abstract][Full Text] [Related]
37. Palliative radiotherapy and chemoradiotherapy in stage IVA/B esophageal cancer patients with dysphagia.
Kawamoto T; Nihei K; Sasai K; Karasawa K
Int J Clin Oncol; 2018 Dec; 23(6):1076-1083. PubMed ID: 30066207
[TBL] [Abstract][Full Text] [Related]
38. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.
Bower M; Jones W; Vessels B; Scoggins C; Martin R
Ann Surg Oncol; 2009 Nov; 16(11):3161-8. PubMed ID: 19636630
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma.
Kawai T; Kochi M; Fujii M; Song K; Hagiwara K; Watanabe M; Matsuno Y; Suda H; Yagi R; Takayama T
Anticancer Res; 2017 Jun; 37(6):3301-3306. PubMed ID: 28551681
[TBL] [Abstract][Full Text] [Related]
40. A new fully covered metal stent for the treatment of benign and malignant dysphagia: a prospective follow-up study.
Hirdes MM; Siersema PD; Vleggaar FP
Gastrointest Endosc; 2012 Apr; 75(4):712-8. PubMed ID: 22284093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
